CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 7 filers reported holding CAN-FITE BIOPHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $448,000 | -13.5% | 508,630 | +8.4% | 0.02% | -21.9% |
| Q4 2018 | $518,000 | +6.1% | 469,130 | +27.1% | 0.03% | +33.3% |
| Q3 2018 | $488,000 | +38.6% | 369,130 | +51.2% | 0.02% | +33.3% |
| Q1 2018 | $352,000 | +46.7% | 244,130 | +57.5% | 0.02% | +28.6% |
| Q4 2017 | $240,000 | – | 155,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TAYLOR ASSET MANAGEMENT INC | 796,500 | $1,434,000 | 0.48% |
| Psagot Value Holdings Ltd. | 34,126 | $61,000 | 0.00% |
| Virtu KCG Holdings LLC | 21,565 | $39,000 | 0.00% |
| MORGAN STANLEY | 12,300 | $22,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 800 | $1,000 | 0.00% |
| Citadel Advisors | 16,738 | $30,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 12,200 | $22,000 | 0.00% |